1. Why Are Women Less Represented in Intracerebral Hemorrhage Trials?
- Author
-
Tatiana Greige, Casey Norton, Lydia D. Foster, Sharon D. Yeatts, Andre Thornhill, Jessica Griffin, Jeffrey Wang, Courtney M. Hrdlicka, Magdy Selim, Yuko Palesch, Aaron Perlmutter, Claudia Moy, Steven Greenberg, Lewis Morgenstern, Daniel Hanley, Guohua Xi, Thomas P Bleck, Robert Balk, Catherine Dillon, Wenle Zhao, Jaemyung Kim, Sandeep Kumar, Megan Farinella, Erica Siwila-Sackman, Caroline Feigert, Gottfried Schlaug, Jasmine Wang, Clinton Wright, Scott Janis, Peter Gilbert, Carlos S Kase, Shannon Carson, Matthew Flaherty, Craig M Kessler, Leslie A McClure, Donna Bannon, Joseph Broderick, and Amy Dill
- Subjects
Adult ,Male ,medicine.medical_specialty ,media_common.quotation_subject ,Deferoxamine ,Article ,Clinical Trials, Phase II as Topic ,Bias ,Double-Blind Method ,Internal medicine ,medicine ,Humans ,Aged ,Cerebral Hemorrhage ,media_common ,Advanced and Specialized Nursing ,Intracerebral hemorrhage ,Selection bias ,business.industry ,Patient Selection ,Middle Aged ,medicine.disease ,Clinical trial ,Lower prevalence ,Female ,Neurology (clinical) ,Cardiology and Cardiovascular Medicine ,business ,medicine.drug - Abstract
Background and Purpose: Fewer women than men tend to be enrolled in clinical trials of intracerebral hemorrhage. It is unclear whether this reflects lower prevalence of intracerebral hemorrhage in women, selection bias, or poor recruitment efforts. We undertook this study to examine differences between men and women in the reasons for exclusion from the iDEF trial (Intracerebral Hemorrhage Deferoxamine). Methods: The screen failure log included 29 different reasons for exclusion. Chi-square statistics were used to evaluate the differences in reasons for exclusion between men and women. Results: A total of 38.2% of participants in iDEF were women. Three thousand nine hundred eighty-two women (45.7%) and 4736 men (54.3%) were screen failures ( P P =0.1). Patients or families declined participation in 1.26% of women versus 1.31% of men ( P =0.9). More women than men failed screening because of age>80 (22.40% versus 12.61%; adjusted P =0.0007) and preexisting do-not-resuscitate/do-not-intubate (3.69% versus 2.83%; adjusted P =0.067). Conclusions: Lower rates of women enrollment in the iDEF trial may be attributed to older age. Inability to obtain consent or declining participation was similar between women and men, arguing against selection bias. Our findings should be confirmed in other intracerebral hemorrhage trials to determine best strategies to improve women’s representation in future trials.
- Published
- 2021
- Full Text
- View/download PDF